Strategic Partnerships CriTech has formed recent strategic partnerships with Parasoft UK Ltd (July 2025) and The Realtime Group (April 2025), signaling openness to expanded collaboration and potential co-delivery of testing, development, and regulatory support services that can be leveraged to cross-sell to medical device makers.

Regulatory Excellence With ISO 13485:2016 certification and a 100% first-time approval rate for submissions to FDA and EU, CriTech positions itself as a trusted provider for compliance, offering a strong risk management, documentation, and SaMD expertise that appeals to manufacturers aiming to accelerate market approvals.

Medical Device Focus Specialization exclusively in medical device software across safety-critical domains, including AI/ML and cybersecurity, creates a differentiated value proposition for customers seeking domain-specific engineering, testing, and remediation capabilities.

Global Growth Readiness Revenue range indicates a mid-market scale with potential for expansion through larger device classes and international regulatory markets, supported by ongoing partnerships and a diverse tech stack that can integrate with customer environments.

Expansion Opportunities Recent alliances and the firm’s long-standing presence in medtech suggest opportunities to upsell services such as due diligence, software documentation, cloud-based solutions, and UI/DB design, targeting manufacturers seeking end-to-end regulatory-compliant software platforms.